Stacks Image 78
Stacks Image 72
Stacks Image 74
Over 70% of all the people approved for Medical Cannabis use in Canada suffer from arthritis. Why such a huge percentage? The Arthritis Society of Canada is a Model Patient Support Group who “GET IT” when it comes to cannabis medicine. If you go to their web site and enter 'Cannabis” in the search window you will get well over 200 hits including these:
Medical Cannabis: What people with arthritis need to know
The Arthritis Society hosts medical cannabis roundtable
Medical Cannabis - Videos on the overview medical cannabis to help understand and manage arthritis.
Exploring whether medical cannabis can mitigate OA neuropathic pain - Chemicals in the cannabis plant have been found to be effective in repairing nerves and alleviating neuropathic pain – meaning that cannabis-like drugs may be more ideal for osteoarthritis OA pain management in some patients than current medications. 

One of the earliest records of medical use of cannabis, a Chinese text dating from ca. 2000 BC, notes that cannabis “undoes rheumatism,” suggesting its anti-inflammatory effects were known even then.

Article from Leafly - Many people know that cannabis medicine can make pain bearable for arthritis sufferers but is it possible that cannabis can retard or even reverse the damage from arthritis inflammation? That is the subject of an exciting new study being done at Dalhousie in Halifax, supported by the Canadian Arthritis Society. This story is fully explored in this article from Leafly, you can easily follow the links to the published science and news behind it. -

Article from Personal Health - Canada’s First Medical Cannabis Trial Seeks New Options For Arthritis Patients -


Article from Vancouver Sun - Arthritis Society offers guide for medical marijuana -

Some of the Published Research
  • The endocannabinoid system and its therapeutic implications in rheumatoid arthritis. - 2015 -
  • The role of the endocannabinoid system in pain. - 2015 -
  • HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. - 2015 -
  • Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells. - 2014 -
  • Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints. - 2014 - - Guidance is required to inform rheumatologists on the evidence regarding cannabinoids.
  • AB1133 Comparison of Canadian and Israeli Rheumatologists' Understanding of Cannabinoid Use as A Therapy for Rheumatic Diseases - 2014 -
  • Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis. - 2014 -
  • The dilemma of medical marijuana use by rheumatology patients. - 2014 -
  • Cannabinoid receptor 2: potential role in immunomodulation and neuroinflammation. - 2013 - - An accumulating body of evidence suggests that endocannabinoids and cannabinoid receptors type 1 and 2 (CB(1), CB(2)) play a significant role in physiologic and pathologic processes, including cognitive and immune functions. . . . there is growing appreciation of the therapeutic potential of cannabinoids in multiple pathologic conditions involving chronic inflammation (inflammatory bowel disease, arthritis, autoimmune disorders, multiple sclerosis, HIV-1 infection, stroke, Alzheimer's disease to name a few), mainly mediated by CB(2) activation.
  • Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis - 2013 -
  • Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. - 2011 -
  • The cannabinergic system as a target for anti-inflammatory therapies. - 2006 -
  • Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis - 2006 -
  • Cannabinoid receptor type 2 gene is associated with human osteoporosis. - 2005 - - CB2 receptors may play a critical role in whether or not you develop bone weakness as you grow older
  • The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis - 2000 -